| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.1 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.27 | 0.1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.072 | 0.1 |